Market Cap 13.46M
Revenue (ttm) 19.63M
Net Income (ttm) -60.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -308.10%
Debt to Equity Ratio 0.00
Volume 397,000
Avg Vol 17,513,275
Day's Range N/A - N/A
Shares Out 41.79M
Stochastic %K 14%
Beta 1.92
Analysts Sell
Price Target $1.00

Company Profile

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothel...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 491 6422
Address:
3675 Market Street, Suite 401, Philadelphia, United States
CaptSparow
CaptSparow Aug. 1 at 3:09 PM
$OCGN @kil0gho5t It was actually predictable. I had questioned previously why they didn't wait until Korea & $CARM were solidified first. That's the route I would have taken. Of course the resident bear Farmer lead with a whole different story in what would transpire during the call. 😂 Dude always front runs his nonsense. All that aside, vote happens next week. Will be interesting to see if it 50:1 ??
1 · Reply
CaptSparow
CaptSparow Aug. 1 at 2:08 PM
$OCGN I told you all @TheUrbanFarmer was a bear. Led you all on you would hear about Korea name, ocu400 updates etc. All BS. The dude pumps & dumps. 😂 BTW, next Tues $CARM votes.
0 · Reply
Theb3lgian01
Theb3lgian01 Jul. 31 at 12:06 PM
$OCGN $CARM Neocart
1 · Reply
Learningstuff
Learningstuff Jul. 30 at 2:49 PM
$CARM can someone explain Sesen 817CVR038's? Are they dead or alive until March 31, 2027. Learning, appreciate the insight.
1 · Reply
TradesBB
TradesBB Jul. 30 at 1:48 PM
1 · Reply
AtotheZ
AtotheZ Jul. 30 at 12:48 PM
$CARM management since EBio
0 · Reply
Pepe2234
Pepe2234 Jul. 29 at 12:15 PM
$CARM carm lag
0 · Reply
CaptSparow
CaptSparow Jul. 29 at 11:21 AM
$OCGN Sometime in August 2025 Ocugen will own $125,000,000 market cap equity in $CARM AFTER $CARM does a reverse split of between 10:1 to 50:1 In turn this new equity will become $OCLX with a per share price of $4 (10:1) to $20 (50:1). So, those screaming Ocugen will do a reverse split have no clue what they are talking about. It's $CARM doing the reverse split BEFORE $OCGN takes over the new ticker $OCLX Imagine that, Ocugen will be sitting on $125,000,000 market cap equity in $OCLX In my neck of the woods that $125,000,000 is a H.E.L.O.C. ( future non dilutive financing, if needed). Unbelievable everyone does not see this.
1 · Reply
CaptSparow
CaptSparow Jul. 28 at 6:52 PM
$OCGN @txphotog @The_Beginner You are honestly the least sharpest knife in the drawer when it comes to being a bear. Perhaps you missed the part where $CARM becomes $125 million market cap equity for $OCGN. Think H.E.L.O.C. and stop being so brain dead. Kids these days.
0 · Reply
Pepe2234
Pepe2234 Jul. 28 at 6:37 PM
$CARM do they offer us lubricant for this
2 · Reply
Latest News on CARM
Carisma Therapeutics Provides Corporate Updates

Mar 31, 2025, 4:30 PM EDT - 4 months ago

Carisma Therapeutics Provides Corporate Updates


Carisma Therapeutics Announces Changes to its Board of Directors

Oct 30, 2024, 4:30 PM EDT - 9 months ago

Carisma Therapeutics Announces Changes to its Board of Directors


Carisma Therapeutics to Present at Upcoming Conferences

Sep 3, 2024, 7:30 AM EDT - 11 months ago

Carisma Therapeutics to Present at Upcoming Conferences


CaptSparow
CaptSparow Aug. 1 at 3:09 PM
$OCGN @kil0gho5t It was actually predictable. I had questioned previously why they didn't wait until Korea & $CARM were solidified first. That's the route I would have taken. Of course the resident bear Farmer lead with a whole different story in what would transpire during the call. 😂 Dude always front runs his nonsense. All that aside, vote happens next week. Will be interesting to see if it 50:1 ??
1 · Reply
CaptSparow
CaptSparow Aug. 1 at 2:08 PM
$OCGN I told you all @TheUrbanFarmer was a bear. Led you all on you would hear about Korea name, ocu400 updates etc. All BS. The dude pumps & dumps. 😂 BTW, next Tues $CARM votes.
0 · Reply
Theb3lgian01
Theb3lgian01 Jul. 31 at 12:06 PM
$OCGN $CARM Neocart
1 · Reply
Learningstuff
Learningstuff Jul. 30 at 2:49 PM
$CARM can someone explain Sesen 817CVR038's? Are they dead or alive until March 31, 2027. Learning, appreciate the insight.
1 · Reply
TradesBB
TradesBB Jul. 30 at 1:48 PM
1 · Reply
AtotheZ
AtotheZ Jul. 30 at 12:48 PM
$CARM management since EBio
0 · Reply
Pepe2234
Pepe2234 Jul. 29 at 12:15 PM
$CARM carm lag
0 · Reply
CaptSparow
CaptSparow Jul. 29 at 11:21 AM
$OCGN Sometime in August 2025 Ocugen will own $125,000,000 market cap equity in $CARM AFTER $CARM does a reverse split of between 10:1 to 50:1 In turn this new equity will become $OCLX with a per share price of $4 (10:1) to $20 (50:1). So, those screaming Ocugen will do a reverse split have no clue what they are talking about. It's $CARM doing the reverse split BEFORE $OCGN takes over the new ticker $OCLX Imagine that, Ocugen will be sitting on $125,000,000 market cap equity in $OCLX In my neck of the woods that $125,000,000 is a H.E.L.O.C. ( future non dilutive financing, if needed). Unbelievable everyone does not see this.
1 · Reply
CaptSparow
CaptSparow Jul. 28 at 6:52 PM
$OCGN @txphotog @The_Beginner You are honestly the least sharpest knife in the drawer when it comes to being a bear. Perhaps you missed the part where $CARM becomes $125 million market cap equity for $OCGN. Think H.E.L.O.C. and stop being so brain dead. Kids these days.
0 · Reply
Pepe2234
Pepe2234 Jul. 28 at 6:37 PM
$CARM do they offer us lubricant for this
2 · Reply
CBARRR8
CBARRR8 Jul. 27 at 1:25 PM
$CARM Looks like my prediction of going down to 1 cent is coming true.
0 · Reply
UtahLife14
UtahLife14 Jul. 26 at 3:46 PM
$CARM Out at $250
0 · Reply
TradesBB
TradesBB Jul. 25 at 2:53 PM
$CARM carm lag
1 · Reply
Pepe2234
Pepe2234 Jul. 25 at 11:46 AM
$CARM when are we getting bent over again?
0 · Reply
InvestingTitan
InvestingTitan Jul. 25 at 1:24 AM
$CARM They shouldn't dilute down here imo
0 · Reply
Tradingistheway
Tradingistheway Jul. 24 at 3:26 PM
1 · Reply
CaptSparow
CaptSparow Jul. 21 at 11:08 AM
$OCGN @TheUrbanFarmer You can pontificate all you wish about "potential" , you can even cry saying the market does not know Ocugen's "potential", you can cry about my posts, you can cry about Ocugen losing almost 11% stock price in the last week, you can cry that I told you at $1.15 the price would be going down (no relevant news). The fact is the market wants RELEVANT news, not fluff, not rehashing already known news, not rocket emojis, not I know better than everybody (Farmer), not LinkedIn posts. Ocugen is way behind on recruiting for ocu400, they are doing a business update BEFORE $CARM vote, BEFORE possible Korean deal. What's the sense of having a business update if one can't give definitive information on the above? It defies logic.
0 · Reply
UtahLife14
UtahLife14 Jul. 21 at 12:49 AM
$CARM just here waiting on my $6 CVR
1 · Reply
CaptSparow
CaptSparow Jul. 18 at 11:52 AM
$OCGN @TBwynn $OCGN Investors are seeking NEWS on the apparent Korea deal and the apparent $CARM deal. Hearing about patient number 1 (of 54 needed) getting dosed for a possible BLA in 2027 is NOT relevant current NEWS IMO. I don't invest in fluff, you do as you wish.
1 · Reply
CaptSparow
CaptSparow Jul. 18 at 1:43 AM
$OCGN Some potential issues ahead. I'm not sure how $OCGN does a business update without being able to conclude what's going on with $CARM at that business update.
2 · Reply
CaptSparow
CaptSparow Jul. 17 at 2:43 PM
$OCGN @LangL They $CARM vote Aug.7 on their reverse split. If that doesn't pass they won't meet their upcoming Nasdaq compliance. $OCGN
2 · Reply
CaptSparow
CaptSparow Jul. 17 at 2:18 PM
$OCGN Should have done the earnings/business update after Aug.7 ($CARM vote).
2 · Reply